Relationship between serum podocalyxin levels with the major risk factors of peripheral artery disease among patients with type 2 diabetes mellitus
Keywords:
Podocalyxin, dyslipidemia, HbA1c, and C-reactive proteinAbstract
Objective and aim: A positive association between serum podocalyxin (PCX) levels and peripheral artery disease has been reported. The aim of this study is to measure the level of serum PCX in patients with T2DM as well as looking for its relation to major PAD risk factors. Methods: Observational crosssectional study was conducted on 200 patients with type 2 diabetes (T2DM) and a control group of 100 apparently healthy subjects (ages 30-65 years). All the participants were investigated for the major risk factors of peripheral artery disease (PAD) which included (cigarette smoking, diabetes mellitus, hypertension, dyslipidemia, obesity, and physical activity). Serum PCX, blood sugar, HbA1c, Lipid profile, C-reactive protein, body weight, and height, were measured in patients and healthy subjects. Results: Significantly higher PCX level (p=0.01) was found in patients compared to controls. Significant differences were found for PCX with body mass index and C – reactive protein (p=0.001 and <0.01 respectively). In the patient group, positive correlations of PCX were observed with BMI, HbA1c, and C-RP (p=0.00, p=0.01, and p=0.001 respectively). BMI was the best predictor of PCX level in both groups. Conclusion: Elevated S.PCX levels in conjunction with increased body weight may be strongly associated with peripheral artery disease in diabetic patients.
Downloads
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.